Turning Point Brands Inc (TPB)

ALP Signs Conor McGregor as Global Brand Partner in Landmark DealMay 20, 2026 10:30 AM
PR Newswire (US) Partnership Marks Major Growth Milestone for One of the Fastest-Rising Nicotine Pouch Brands in the IndustryMIAMI, May 20, 2026 /PRNewswire/ -- ALP, one of the fastest-growing nicotine pouch brands in the market, today announced a landmark partnership with global combat sports icon Conor McGregor, officially welcoming the UFC champion to the ALP family. The announcement comes at a pivotal moment for both the brand and McGregor, as anticipation builds around his highly anticipated return during International Fight Week in July.Founded less than two years ago, ALP has rapidly emerged as a disruptive force within the nicotine pouch category, scaling at an accelerated pace through premium product experience, bold branding, and culturally driven marketing.Polina Lutsenko, Director of Partnerships, says: "ALP was built around a bold, unapologetic mindset, and there's no one in combat sports who represents that spirit more authentically than Conor McGregor. He's become a global icon through relentless drive, confidence, and an ability to command attention both inside and outside the octagon."The partnership signals ALP's continued investment in sports, culture, and large-scale brand storytelling as the company accelerates expansion across retail, digital, and experiential channels."Conor's massive global audience combined with our team's ability to tell great stories is a knockout combination. We view this partnership as a continuation of our strategy to partner with authentic people who align with our vision. We look forward to this creative partnership as we expand internationally this summer," said ALP's CEO, Lorenzo De Plano.As part of the collaboration, ALP and McGregor will launch a 360 omnichannel marketing campaign produced by CFH. Studio, spanning broadcast, digital, social, and experiential activations designed to bring fans inside Conor's world. The partnership will roll out across high-impact moments throughout the year, anchored by International Fight Week and extending through key cultural tentpoles.Conor McGregory says: "The pouch market is surging in popularity, and ALP is a global leader. Together we will fuel the growth and reach new markets"The collaboration is planned alongside ALP's international expansion plans. ALP is planning to launch in the EU and South America later this year.About ALP Supply Co.ALP is a next-generation nicotine brand redefining the category through a focus on quality, experience, and independence. Built outside traditional corporate systems, ALP creates products for consumers who value performance, intentionality, and doing things their own way. ALP Supply Co. LLC is jointly owned by Turning Point Brands (NYSE: TPB) and Tucker Carlson Network (TCN).www.alppouches.com View original content to download multimedia:https://www.prnewswire.com/news-releases/alp-signs-conor-mcgregor-as-global-brand-partner-in-landmark-deal-302777830.htmlSOURCE ALP Supply Co. LLC Original: ALP Signs Conor McGregor as Global Brand Partner in Landmark Deal

Turning Point Brands Announces First Quarter 2026 ResultsMay 7, 2026 7:30 AM
Business Wire Q1 2026 Modern Oral Net Sales increased 133% to $52.0 million, accounting for 42% of total company net sales, up from 21% in Q1 2025. Raising FY 2026 Modern Oral Sales guidance; Introducing FY 2026 EBITDA guidance. Turning Point Brands, Inc. (“TPB” or “the Company”) (NYSE: TPB), a manufacturer, marketer and distributor of branded consumer products, including alternative smoking accessories and consumables with active ingredients, today announced financial results for the first quarter ended March 31, 2026. Q1 2026 Financial Highlights
(All results reflect comparisons to prior-year period) Total Consolidated Net Sales increased 16.8% to $124.3 million Stoker's segment Net Sales increased 48.1% Zig-Zag segment Net Sales decreased 22.4% Gross Profit increased 14.6% to $68.3 million Net Income decreased 19.0% to $11.7 million Adjusted EBITDA decreased 6.5% to $25.9 million (see Schedule A for a reconciliation to net income) Diluted EPS of $0.60 and Adjusted Diluted EPS of $0.76 compared to $0.79 and $0.91 respectively, in the same period one year ago (see Schedule B for a reconciliation to Diluted EPS) “We delivered a strong first quarter, driven by continued momentum in Modern Oral and disciplined execution across the portfolio,” said Graham Purdy, President and CEO. “We believe we are in the early stages of a generational shift in nicotine consumption, with significant opportunity ahead as the category continues to evolve. We are investing behind our brands, commercial capabilities, and consumer reach to position us to capture meaningful share in white pouch, including through initiatives such as our recently announced TKO partnership featuring UFC. At the same time, our legacy brands continue to generate strong cash flow, providing the foundation to fund our strategic priorities. We remain confident in our ability to scale our modern oral business and drive long-term value for shareholders.” Stoker’s Products Segment (70% of total net sales in the quarter) For the first quarter, Stoker’s segment net sales increased 48.1% from the prior year to $87.6 million, driven by triple-digit growth in Modern Oral net sales. For the first quarter, Stoker’s segment gross profit increased 39.1% from the prior year to $47.3 million. Gross profit as a percentage of net sales decreased to 54.0% for the three months ended March 31, 2026, from 57.5% of net sales for the three months ended March 31, 2025, primarily driven by margin contribution from modern oral products. Zig-Zag Products Segment (30% of total net sales in the quarter) For the first quarter, Zig-Zag segment net sales decreased 22.4% from the prior year to $36.7 million. The decrease in net sales was driven primarily by lower U.S. papers and wraps shipments. For the first quarter, Zig-Zag segment gross profit decreased 18.1% from the prior year to $20.9 million. Gross profit as a percentage of net sales increased to 57.1% for the three months ended March 31, 2026, from 54.1% for the three months ended March 31, 2025, driven primarily by product mix. Performance Measures in the First Quarter Investment in the first quarter focused on sales and marketing efforts to support distribution and brand building. In the first quarter consolidated selling, general and administrative (“SG&A”) expenses increased 53.2% from the prior year to $55.8 million, inclusive of Modern Oral-related sales and marketing investments and increased outbound freight costs. As of March 31, 2026, ending cash was $192.4 million and net debt was $101.4 million. The Company ended the quarter with total liquidity of $265.0 million, comprised of $192.4 million in cash and $72.6 million of asset backed revolving credit facility capacity. 2026 Outlook Full year Modern Oral Gross Sales of $280-$300 million (from $220- $240 million) Full year Modern Oral Net Sales of $210-$225 million (from $180- $190 million) Full Year Adjusted EBITDA of $70-$90 million, inclusive of investment in Modern Oral sales, marketing, and trade promotions Earnings Conference Call As previously disclosed, a conference call with the investment community to review TPB’s financial results has been scheduled for 8:30 a.m. Eastern on Thursday, May 7, 2026. Investment community participants should dial in 10 minutes ahead of time using the toll-free number (800) 715-9871 (international participants should call (646) 307-1963) and follow the audio prompts after typing in the event ID: 4128483. A live listen-only webcast of the call will be available on the Events and Presentations section of the investor relations portion of the Company website (www.turningpointbrands.com). A replay of the webcast will be available on the site two hours following the call. Non-GAAP Financial Measures In addition to financial measures prepared in accordance with generally accepted accounting principles in the United States (GAAP), this press release includes certain non-GAAP financial measures including EBITDA, Adjusted EBITDA, Adjusted Net Income, Adjusted Diluted EPS, Free Cash Flow, and Adjusted Operating Income (Loss). A reconciliation of these non-GAAP financial measures accompanies this release. Also note that a reconciliation of forward-looking non-GAAP measures, including EBITDA, to the most directly comparable GAAP measures is not provided because comparable GAAP measures for such measures are not reasonably accessible or reliable due to the inherent difficulty in forecasting and quantifying measures that would be necessary for such reconciliation. About Turning Point Brands, Inc. Turning Point Brands, Inc. (NYSE: TPB) is a manufacturer, marketer and distributor of branded consumer products including alternative smoking accessories and consumables with active ingredients through its iconic brand portfolio, including Zig-Zag®, Stoker’s®, FRE®, and ALP®. TPB’s products are available in more than 220,000 retail outlets in North America and on sites such as www.zigzag.com, www.frepouch.com, and www.alppouch.com. For the latest news and information about TPB and its brands, please visit www.turningpointbrands.com. Forward-Looking Statements This press release contains forward-looking statements within the meaning of the federal securities laws, including our outlook for 2026 with respect to Modern Oral Gross and Net Sales and Adjusted EBIDTA. Forward-looking statements may generally be identified by the use of words such as "anticipate," "believe," "expect," "intend," "plan" and "will" or, in each case, their negative, or other variations or comparable terminology. These forward-looking statements include all matters that are not historical facts. By their nature, forward-looking statements involve risks and uncertainties because they relate to events and depend on circumstances that may or may not occur in the future. As a result, these statements are not guarantees of future performance and actual events may differ materially from those expressed in or suggested by the forward-looking statements. Any forward-looking statement made by TPB in this press release, its reports filed with the Securities and Exchange Commission (the “SEC”) and other public statements made from time-to-time speak only as of the date made. New risks and uncertainties come up from time to time, and it is impossible for TPB to predict or identify all such events or how they may affect it. TPB has no obligation, and does not intend, to update any forward-looking statements after the date hereof, except as required by federal securities laws. Factors that could cause these differences include, but are not limited to, those included in the Company’s Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q and other reports filed by the Company with the SEC. These statements constitute the Company’s cautionary statements under the Private Securities Litigation Reform Act of 1995. This press release contains TPB’s preliminary determinations and current expectations, and such information is inherently uncertain. The preliminary estimates provided herein have been prepared by, and are the responsibility of, management and are subject to completion of TPB's customary quarter-end closing and review procedures and third-party review. As a result, TPB's reported information in its Quarterly Report on Form 10-Q for the quarter ended March 31, 2026 may differ from this information, and any such differences may be material. In addition, the information furnished above does not include all of the information regarding TPB's financial condition and results of operations for the quarter ending March 31, 2026 that may be important to readers. As a result, readers are cautioned not to place undue reliance on the information furnished in this press release and should view this information in the context of TPB's full first quarter 2026 results when such results are disclosed by TPB in its Quarterly Report on Form 10-Q for the quarter ended March 31, 2026. Financial Statements Follow on Subsequent Pages Turning Point Brands, Inc. Consolidated Statements of Income (dollars in thousands except share data) (unaudited)     Three Months Ended March 31,       2026     2025   Net sales   $ 124,278     $ 106,436   Cost of sales     55,983       46,826   Gross profit     68,295       59,610   Selling, general, and administrative expenses     55,811       36,421   Operating income     12,484       23,189   Other expense, net     63       -   Interest expense, net     4,423       4,414   Investment gain     (151 )     (141 ) Income from equity method investment     (2,983 )     (150 ) Loss on extinguishment of debt     -       1,235   Income from continuing operations before income taxes     11,132       17,831   Income tax (benefit) expense     (2,810 )     2,040   Consolidated net income     13,942       15,791   Net income attributable to non-controlling interest     2,275       1,396   Net income attributable to Turning Point Brands, Inc.   $ 11,667     $ 14,395                     Basic income per common share:                 Net income attributable to Turning Point Brands, Inc.   $ 0.61     $ 0.81   Diluted income per common share:                 Net income attributable to Turning Point Brands, Inc.   $ 0.60     $ 0.79   Weighted average common shares outstanding:                 Basic     19,214,389       17,795,243   Diluted     19,474,877       18,249,306   Turning Point Brands, Inc. Consolidated Balance Sheets (dollars in thousands except share data) (unaudited)     March 31,     December 31,   ASSETS   2026     2025   Current assets:                 Cash   $ 192,439     $ 222,760   Accounts receivable, net of allowances of $228 in 2026 and $206 in 2025     27,473       25,726   Inventories, net     129,580       107,989   Other current assets     68,712       60,675   Total current assets     418,204       417,150   Property, plant, and equipment, net     40,584       36,247   Right of use assets     15,409       14,480   Deferred financing costs, net     1,019       1,180   Goodwill     135,974       136,097   Other intangible assets, net     63,731       64,042   Master Settlement Agreement (MSA) escrow deposits     29,786       29,887   Other assets     67,390       64,667   Total assets   $ 772,097     $ 763,750                     LIABILITIES AND STOCKHOLDERS’ EQUITY                 Current liabilities:                 Accounts payable   $ 35,889     $ 20,420   Accrued liabilities     35,394       54,587   Total current liabilities     71,283       75,007   Deferred income tax liability     8,363       8,289   Notes payable and long-term debt     293,885       293,625   Other long-term liabilities     2,034       4,138   Lease liabilities     11,043       10,708   Total liabilities     386,608       391,767                     Stockholders’ equity:                 Preferred stock, $0.01 par value; authorized shares 40,000,000; issued and outstanding shares -0-     -       -   Common stock, voting, $0.01 par value; authorized shares, 190,000,000; 20,824,677 issued shares and 19,367,534 outstanding shares at March 31, 2026, and 20,589,527 issued shares and 19,132,384 outstanding shares at December 31, 2025     218       216   Common stock, nonvoting, $0.01 par value; authorized shares, 10,000,000; issued and outstanding shares -0-     -       -   Additional paid-in capital     205,542       203,627   Cost of repurchased common stock (1,457,143 shares at March 31, 2026 and 1,457,143 shares at December 31, 2025)     (47,637 )     (47,637 ) Accumulated other comprehensive loss     (2,090 )     (1,563 ) Accumulated earnings     209,730       199,661   Non-controlling interest     19,726       17,679   Total stockholders’ equity     385,489       371,983   Total liabilities and stockholders’ equity   $ 772,097     $ 763,750   Turning Point Brands, Inc. Consolidated Statements of Cash Flows (dollars in thousands) (unaudited)     Three Months Ended March 31,       2026     2025   Cash flows from operating activities:                 Consolidated net income   $ 13,942     $ 15,791   Adjustments to reconcile net income to net cash provided by operating activities:                 Loss on extinguishment of debt     -       1,235   Loss on sale of property, plant, and equipment     -       40   Income from equity method investment     (2,983 )     (150 ) Gain on investments     (15 )     -   Depreciation and other amortization expense     1,753       1,309   Amortization of other intangible assets     306       307   Amortization of deferred financing costs     421       448   Deferred income tax expense     96       1,716   Stock compensation expense     2,938       1,664   Noncash lease income     (807 )     (380 ) Changes in operating assets and liabilities:                 Accounts receivable     (1,941 )     (5,539 ) Inventories     (21,700 )     (8,310 ) Other current assets     (8,062 )     (5,399 ) Other assets     (108 )     (1,268 ) Accounts payable     15,637       15,433   Accrued liabilities and other     (21,736 )     512   Net cash (used in) provided by operating activities   $ (22,259 )   $ 17,409                     Cash flows from investing activities:                 Capital expenditures   $ (5,139 )   $ (2,185 ) Payment for equity investments     -       (2,783 ) Purchases of investments     (2,283 )     (714 ) Proceeds from sale of investments     2,351       500   MSA escrow deposits, net     5       (48 ) Net cash used in investing activities   $ (5,066 )   $ (5,230 )                   Cash flows from financing activities:                 Redemption of 2026 Notes   $ -     $ (250,000 ) Proceeds from 2032 Notes     -       300,000   Payment of dividends     (1,671 )     (1,385 ) Payments of financing costs     -       (6,582 ) Exercise of options     323       973   Redemption of options     -       (33 ) Redemption of restricted stock units     (330 )     (1,828 ) Redemption of performance based restricted stock units     (1,014 )     (2,625 ) Net cash (used in) provided by financing activities   $ (2,692 )   $ 38,520                     Net (decrease) increase in cash   $ (30,017 )   $ 50,699   Effect of foreign currency translation on cash   $ (304 )   $ (48 )                   Cash, beginning of period:                 Unrestricted   $ 222,760     $ 48,941   Restricted     1,914       1,961   Total cash at beginning of period   $ 224,674     $ 50,902                     Cash, end of period:                 Unrestricted   $ 192,439     $ 99,640   Restricted     1,914       1,913   Total cash at end of period   $ 194,353     $ 101,553   Non-GAAP Financial Measures To supplement our financial information presented in accordance with generally accepted accounting principles in the United States, or U.S. GAAP, we use non-U.S. GAAP financial measures, including EBITDA, Adjusted EBITDA, Adjusted Net Income, Adjusted Diluted EPS, and Adjusted Operating Income (Loss). We believe Adjusted EBITDA provides useful information to management and investors regarding certain financial and business trends relating to our financial condition and results of operations. Adjusted EBITDA, Adjusted Net Income, Adjusted Diluted EPS, and Adjusted Operating Income (Loss) are used by management to compare our performance to that of prior periods for trend analyses and planning purposes and are presented to our board of directors. We believe that EBITDA, Adjusted EBITDA, Adjusted Net Income, Adjusted Diluted EPS, Free Cash Flow, and Adjusted Operating Income (Loss) are appropriate measures of operating performance because they eliminate the impact of expenses that do not relate to business performance. We define “EBITDA” as net income before interest expense, gain (loss) on extinguishment of debt, income tax expense, depreciation, amortization. We define “Adjusted EBITDA” as net income before interest expense, gain (loss) on extinguishment of debt, income tax expense, depreciation, amortization, other non-cash items and other items that we do not consider ordinary course in our evaluation of ongoing operating performance. We define “Adjusted Net Income” as net income excluding items that we do not consider ordinary course in our evaluation of ongoing operating performance. We define “Adjusted Diluted EPS” as diluted earnings per share excluding items that we do not consider ordinary course in our evaluation of ongoing operating performance. We define “Adjusted Operating Income (Loss)” as operating income (loss) excluding other non-cash items and other items that we do not consider ordinary course in our evaluation of ongoing operating performance. Non-U.S. GAAP measures should not be considered a substitute for, or superior to, financial measures calculated in accordance with U.S. GAAP. EBITDA, Adjusted Net Income, Adjusted EBITDA, Adjusted Diluted EPS, and Adjusted Operating Income (Loss) exclude significant expenses that are required by U.S. GAAP to be recorded in our financial statements and is subject to inherent limitations. In addition, other companies in our industry may calculate this non-U.S. GAAP measure differently than we do or may not calculate it at all, limiting its usefulness as a comparative measure. In accordance with SEC rules, we have provided, in the supplemental information attached, a reconciliation of the non-GAAP measures to the next directly comparable GAAP measures. Note that a reconciliation of forward-looking non-GAAP measures, including EBITDA, to the most directly comparable GAAP measures is not provided because comparable GAAP measures for such measures are not reasonably accessible or reliable due to the inherent difficulty in forecasting and quantifying measures that would be necessary for such reconciliation. Schedule A   Turning Point Brands, Inc. Reconciliation of GAAP Net Income to Adjusted EBITDA (dollars in thousands) (unaudited)       Three Months Ended       March 31,       2026     2025   Net income attributable to Turning Point Brands, Inc.   $ 11,667     $ 14,395   Add:                 Interest expense, net     4,569       4,401   Loss on extinguishment of debt     -       1,235   Income tax (benefit) expense     (2,492 )     2,040   Depreciation expense     794       828   Amortization expense     1,285       822   EBITDA   $ 15,823     $ 23,721   Components of Adjusted EBITDA                 Corporate restructuring (a)     97       -   ERP/CRM (b)     -       211   Stock based compensation (c)     2,938       1,664   Transactional expenses and strategic initiatives (d)     145       176   Non-recurring legal (e)     153       -   FDA PMTA (f)     290       1,591   Mark-to-market gain on Canadian inter-company note (g)     (116 )     315   Tariff adjustment (h)     5,903       -   Manufacturing start-up costs (i)     594       -   Honorarium (j)     63       -   Adjusted EBITDA   $ 25,890     $ 27,678     (a) Represents costs associated with corporate restructuring, including severance and early retirement. (b) Represents cost associated with scoping and mobilization of new ERP and CRM systems and cost of duplicative ERP licenses. (c) Represents non-cash stock options, restricted stock, PSRUs, etc. (d) Represents the fees incurred for transaction expenses. (e) Represents legal expenses incurred in connection with litigation related to an insurance claim. (f) Represents costs associated with applications related to FDA premarket tobacco production application ("PMTA").The PMTA regime requires the Company to submit an application to the FDA to receive marketing authorization to continue to sell certain of its product lines with continued sales permitted during the pendency of the applications. The application is a one-time resource-intensive process for each covered product line; however, due to the nature of the implementation process for those product lines already in the market, applications can take multiple years to complete rather than the typical one-time submission. The Company currently has only two product lines currently subject to the PMTA process, having utilized other regulatory pathway options available for our other product lines. The Company does not expect to submit additional PMTA applications for any new product lines after the submission for the pending two are complete. (g) Represents a mark-to-market loss attributable to foreign exchange fluctuation. (h) Represents adjustment to current period costs of goods sold to exclude tariffs subject to refund. (i) Represents non-recurring expenses incurred during the start-up of manufacturing lines. (j) Represents an honorarium gift included in other expense, net. Schedule B   Turning Point Brands Reconciliation of GAAP Net Income to Adjusted Net Income and Diluted EPS to Adjusted Diluted EPS (dollars in thousands except share data) (unaudited)     Three Months Ended     Three Months Ended       March 31, 2026     March 31, 2025       Income from continuing operations before income taxes     Income tax expense (m)     Net loss attributable to non- controlling interest     Adjusted Net Income     Adjusted Diluted EPS     Income from continuing operations before income taxes     Income tax expense (m)     Net loss attributable to non- controlling interest     Net Income     Diluted EPS   GAAP Net Income and Diluted EPS   $ 11,132     $ (2,810 )   $ 2,275     $ 11,667     $ 0.60     $ 17,831     $ 2,040     $ 1,396     $ 14,395     $ 0.79                                                                                     Loss on extinguishment of debt (a)     -       -       -       -       -       1,235       141       -       1,094       0.06   Corporate restructuring (b)     97       (24 )     -       121       0.01       -       -       -       -       -   ERP/CRM (c)     -       -       -       -       -       211       24       -       187       0.01   Stock based compensation (d)     2,938       (742 )     -       3,680       0.19       1,664       190       -       1,474       0.08   Transactional expenses and strategic initiatives(e)     145       (37 )     -       182       0.01       176       20       -       156       0.01   Non-recurring legal (f)     153       (39 )     -       192       0.01       -       -       -       -       -   FDA PMTA (g)     290       (73 )     -       363       0.02       1,591       182       -       1,409       0.08   Mark-to-market loss on Canadian inter-company note (h)     (116 )     29       -       (145 )     (0.01 )     315       36       -       279       0.02   Tariff adjustment (i)     5,903       (1,490 )     -       7,393       0.38       -       -       -       -       -   Manufacturing start-up costs (j)     594       (150 )     -       744       0.04       -       -       -       -       -   Honorarium (k)     63       (16 )     -       79       0.00       -       -       -       -       -   Tax benefit (l)     -       9,475       -       (9,475 )     (0.49 )     -       2,329       -       (2,329 )     (0.13 ) Adjusted Net Income and Adjusted Diluted EPS   $ 21,199     $ 4,124     $ 2,275     $ 14,800     $ 0.76     $ 23,023     $ 4,963     $ 1,396     $ 16,664     $ 0.91     (a) Represents loss on extinguishment of debt as a result of the redemptions of the 2026 Notes. (b) Represents costs associated with corporate restructuring, including severance and early retirement. (c) Represents cost associated with scoping and mobilization of new ERP and CRM systems and cost of duplicative ERP licenses. (d) Represents non-cash stock options, restricted stock, PSRUs, etc. (e) Represents the fees incurred for transaction expenses. (f) Represents legal expenses incurred in connection with litigation related to an insurance claim. (g) Represents costs associated with applications related to FDA premarket tobacco production application ("PMTA").The PMTA regime requires the Company to submit an application to the FDA to receive marketing authorization to continue to sell certain of its product lines with continued sales permitted during the pendency of the applications. The application is a one-time resource-intensive process for each covered product line; however, due to the nature of the implementation process for those product lines already in the market, applications can take multiple years to complete rather than the typical one-time submission. The Company currently has only two product lines currently subject to the PMTA process, having utilized other regulatory pathway options available for our other product lines. The Company does not expect to submit additional PMTA applications for any new product lines after the submission for the pending two are complete. (h) Represents a mark-to-market loss attributable to foreign exchange fluctuation. (i) Represents adjustment to current period costs of goods sold to exclude tariffs subject to refund. (j) Represents non-recurring expenses incurred during the start-up of manufacturing lines. (k) Represents an honorarium gift included in other expense, net. (l) Represents adjustment from quarterly tax rate to quarterly projected tax rate of 24% in 2026 and 21% in 2025. (m) Income tax expense calculated using the effective tax rate for the quarter of -25.2% in 2026 and 11.4% in 2025.   View source version on businesswire.com: https://www.businesswire.com/news/home/20260507230137/en/ Investor Contacts
Turning Point Brands, Inc.
ir@tpbi.com Original: Turning Point Brands Announces First Quarter 2026 Results

Turning Point Brands Declares Common Stock DividendMay 4, 2026 5:20 PM
Business Wire The Board of Directors of Turning Point Brands, Inc. (“TPB”) (NYSE: TPB), a manufacturer, marketer and distributor of branded consumer products including alternative smoking accessories and consumables with active ingredients, declared a regular quarterly dividend of $0.08 per common share. The dividend is payable on July 10, 2026 to shareholders of record on the close of business on June 19, 2026. About Turning Point Brands, Inc. Turning Point Brands, Inc. (NYSE: TPB) is a manufacturer, marketer and distributor of branded consumer products including alternative smoking accessories and consumables with active ingredients through its iconic brand portfolio, including Zig-Zag®, Stoker’s®, FRE®, and ALP®. TPB’s products are available in more than 220,000 retail outlets in North America and on sites such as www.zigzag.com, www.frepouch.com, and www.alppouch.com. For the latest news and information about TPB and its brands, please visit www.turningpointbrands.com. View source version on businesswire.com: https://www.businesswire.com/news/home/20260504032172/en/ ir@tpbi.com Original: Turning Point Brands Declares Common Stock Dividend

Turning Point Brands to Host Q1 2026 Conference CallApril 27, 2026 5:42 PM
Business Wire
Turning Point Brands, Inc. (NYSE: TPB) announced the date and time for its conference call to review first quarter 2026 results. The conference call will be on Thursday, May 7, 2026 at 8:30 a.m. Eastern Time.


Interested analysts and professional investors can register and participate through one of these call-in numbers:


(800) 715-9871 (U.S., toll-free)

(646) 307-1963 (International)

Event ID: 4128483


Participants should dial in at least ten minutes in advance and follow the audio prompts after typing in the Event ID. The call will also be broadcast live as a listen-only webcast from the investor relations section of the company's website at http://www.turningpointbrands.com/investor-relations/events-and-presentations. The replay of the webcast will be available on the site two hours following the call.


About Turning Point Brands, Inc.


Turning Point Brands, Inc. (NYSE: TPB) is a manufacturer, marketer and distributor of branded consumer products including alternative smoking accessories and consumables with active ingredients through its iconic brand portfolio, including Zig-Zag®, Stoker’s®, FRE®, and ALP®. TPB’s products are available in more than 220,000 retail outlets in North America and on sites such as www.zigzag.com, www.frepouch.com, and www.alppouch.com. For the latest news and information about TPB and its brands, please visit www.turningpointbrands.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260427611019/en/
ir@tpbi.com  


Original: Turning Point Brands to Host Q1 2026 Conference Call

I recommend they rebrand, with a new name. This one is incredibly tarnished.

They are focusing on nicotine patch market. Targeting a non-tobacco demographic.

Company Website https://www.turningpointbrands.com/home/default.aspx